Author:
Malviya Vibhav,Singh Harbans,Dwivedi U. S.,Usha �,Singh P. B.
Publisher
Springer Science and Business Media LLC
Reference16 articles.
1. Brandau S, Bohle A (2001) Bladder cancer. I. Molecular and genetic basis of carcinogenesis. Eur Urol 39: 491
2. Dahse R, Utting M, Werner W, Schimmel B, Claussen U, Junker K (2002) TP53 alterations as a potential diagnostic marker in superficial bladder carcinoma and in patients serum, plasma and urine samples. Int J Oncol 20: 107
3. Krajewska B, Lutz W, Pilacik B (1998) Determination of blood serum oncoprotein NEU and antioncoprotein p53?molecular biomarkers in various types of occupational exposure. Int J Occup Med Environ Health 11: 343
4. Schmitz-Drager BJ, Goebell PJ, Ebert T, Fradet Y (2000) P53 immunohistochemistry as a prognostic marker in bladder cancer. Playground for urology scientists? Eur Urol 38: 691
5. Finlay CA, Hinds PW, Tan TH (1988) Activating mutations for the transformation by p53 produce a gene product that forms an hsc-p53 complex with an altered half life. Mol Cell Biol 8: 531
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献